These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18064566)

  • 1. Common genetic variation in the IGF-1 gene, serum IGF-I levels and breast density.
    Verheus M; McKay JD; Kaaks R; Canzian F; Biessy C; Johansson M; Grobbee DE; Peeters PH; van Gils CH
    Breast Cancer Res Treat; 2008 Nov; 112(1):109-22. PubMed ID: 18064566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
    Diorio C; Brisson J; Bérubé S; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):880-8. PubMed ID: 18398029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premenopausal insulin-like growth factor-I serum levels and changes in breast density over menopause.
    Verheus M; Peeters PH; Kaaks R; van Noord PA; Grobbee DE; van Gils CH
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):451-7. PubMed ID: 17372240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary growth hormone and growth hormone-releasing hormone receptor genes and associations with mammographic measures and serum growth hormone.
    Mulhall C; Hegele RA; Cao H; Tritchler D; Yaffe M; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2648-54. PubMed ID: 16284391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density.
    Taverne CW; Verheus M; McKay JD; Kaaks R; Canzian F; Grobbee DE; Peeters PH; van Gils CH
    Breast Cancer Res Treat; 2010 Oct; 123(3):843-55. PubMed ID: 20155489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women.
    Johansson H; Gandini S; Bonanni B; Mariette F; Guerrieri-Gonzaga A; Serrano D; Cassano E; Ramazzotto F; Baglietto L; Sandri MT; Decensi A
    Breast Cancer Res Treat; 2008 Mar; 108(1):57-67. PubMed ID: 17468953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of insulin-like growth factors on the strength of the relation of vitamin D and calcium intakes to mammographic breast density.
    Diorio C; Bérubé S; Byrne C; Mâsse B; Hébert-Croteau N; Yaffe M; Coté G; Pollak M; Brisson J
    Cancer Res; 2006 Jan; 66(1):588-97. PubMed ID: 16397276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations.
    Khoury-Shakour S; Lejbkowicz F; Barnett-Griness O; Tamir A; Pinchev M; Rennert G
    Eur J Cancer Prev; 2009 Sep; 18(5):361-7. PubMed ID: 19543094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
    Al-Zahrani A; Sandhu MS; Luben RN; Thompson D; Baynes C; Pooley KA; Luccarini C; Munday H; Perkins B; Smith P; Pharoah PD; Wareham NJ; Easton DF; Ponder BA; Dunning AM
    Hum Mol Genet; 2006 Jan; 15(1):1-10. PubMed ID: 16306136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study.
    Deming SL; Ren Z; Wen W; Shu XO; Cai Q; Gao YT; Zheng W
    Breast Cancer Res Treat; 2007 Sep; 104(3):309-19. PubMed ID: 17063263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk.
    Fehringer G; Boyd NF; Knight JA; Paterson AD; Dite GS; Giles GG; Southey MC; Andrulis IL; Hopper JL; Ozcelik H
    Breast Cancer Res Treat; 2009 Nov; 118(2):415-24. PubMed ID: 19229608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort.
    Rinaldi S; Biessy C; Hernandez M; Lesueur F; dos-Santos-Silva I; Rice MS; Lajous M; Lopez-Ridaura R; Torres-Mejía G; Romieu I
    Int J Cancer; 2014 Mar; 134(6):1436-44. PubMed ID: 24037648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential clinical applications of insulin-like growth factor-1 ligand in human breast cancer.
    Chong YM; Subramanian A; Sharma AK; Mokbel K
    Anticancer Res; 2007; 27(3B):1617-24. PubMed ID: 17595785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
    Cox DG; Blanché H; Pearce CL; Calle EE; Colditz GA; Pike MC; Albanes D; Allen NE; Amiano P; Berglund G; Boeing H; Buring J; Burtt N; Canzian F; Chanock S; Clavel-Chapelon F; Feigelson HS; Freedman M; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel L; Kraft P; LeMarchand L; Lund E; Palli D; Peeters PH; Riboli E; Stram DO; Thun M; Tjonneland A; Trichopoulos D; Yeager M;
    Breast Cancer Res; 2006; 8(5):R54. PubMed ID: 16987421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density.
    Lai JH; Vesprini D; Zhang W; Yaffe MJ; Pollak M; Narod SA
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):573-82. PubMed ID: 15066922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway.
    Vatten LJ; Holly JM; Gunnell D; Tretli S
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2097-100. PubMed ID: 18708402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-1 CA repeat variant and breast cancer risk in postmenopausal women.
    González-Zuloeta Ladd AM; Liu F; Houben MP; Arias Vásquez A; Siemes C; Janssens AC; Coebergh JW; Hofman A; Janssen JA; Stricker BH; van Duijn CM
    Eur J Cancer; 2007 Jul; 43(11):1718-22. PubMed ID: 17561390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis.
    Pasanisi P; Venturelli E; Morelli D; Fontana L; Secreto G; Berrino F
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1719-22. PubMed ID: 18628423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The GH1/IGF-1 axis polymorphisms and their impact on breast cancer development.
    Wagner K; Hemminki K; Försti A
    Breast Cancer Res Treat; 2007 Sep; 104(3):233-48. PubMed ID: 17082888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.